Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 2,172 shares at $65.20 ($142K) on 2026-04-29, disclosed to the SEC on 2026-05-01.
Open-market sale of $142k WGS by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.12 | 18 | $1K | 0.8% |
| 2 | $65.20 | 2,154 | $140K | 99.2% |
| Total | $65.19 avg | 2,172 | $142K | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-03-30 | $5.9M | — | Filing → |